-
1 Comment
Nava Bharat Ventures Limited is currently in a long term uptrend where the price is trading 67.2% above its 200 day moving average.
From a valuation standpoint, the stock is 91.2% cheaper than other stocks from the Utilities sector with a price to sales ratio of 0.4.
Nava Bharat Ventures Limited's total revenue rose by 21.5% to $7B since the same quarter in the previous year.
Its net income has increased by 169.0% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 1.1% to $4B since the same quarter in the previous year.
Based on the above factors, Nava Bharat Ventures Limited gets an overall score of 4/5.
Exchange | NSE |
---|---|
CurrencyCode | INR |
Industry | Conglomerates |
ISIN | INE725A01022 |
Sector | Industrials |
Beta | 0.87 |
---|---|
Dividend Yield | 3.1% |
Market Cap | 29B |
PE Ratio | 5.82 |
Target Price | None |
Nava Bharat Ventures Limited engages in the ferro alloys, power, mining, and healthcare businesses in India, Zambia, Hong Kong, Japan, and internationally. It generates and sells power using coal, biomass, biogas, and bagasse. The company operates 150 MW and 114 MW power plants in Paloncha, Telangana; 150 MW power plant in Kharagprasad, Odisha; 20 MW biomass power plant in Dharmavaram, Andhra Pradesh; and 300 MW thermal power plant in Zambia. It also mines coal at Maamba in Southern province of Zambia, as well as provides operation and maintenance services for power plants. In addition, the company various alloy metals, such as ferro chrome, silico manganese, ferro silicon, and chromium alloys that are used in automotive, railways, and construction industries, as well as in the manufacture of stainless-steel consumer goods. Further, it operates a medical clinic for the management of iron deficiency and the administration of intravenous iron in Singapore. Additionally, the company manages The Iron Suites Medical Center and corporate healthcare programmes; organizes medical congresses and awareness programmes; and in-licenses pharmaceutical products. The company was incorporated in 1972 and is based in Hyderabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NBVENTURES.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025